BIIB021 (CNF2024)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BIIB021 (CNF2024), covering 2012-06-08 to 2012-06-08. Get the full timeline:
Most recent: Clinical Trial Update: CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD Study [Phase 1]